Altered co-stimulatory and inhibitory receptors on monocyte subsets in patients with visceral leishmaniasis
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012417 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Emebet Adem und 6 weiteren Autor:innen. Beteiligte Einrichtung: Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Monocytes, CD40 Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Visceral leishmaniasis (VL) is a neglected tropical disease caused by parasites from the Leishmania ( L .) donovani complex. VL is characterised by uncontrolled parasite replication in spleen, liver and bone marrow, and by an impaired immune response and high systemic levels of inflammation. Monocytes have been poorly characterised in VL patients. The aim of this study was to evaluate the expression levels of markers involved in the regulation of T cell responses on different subsets of monocytes from the blood of VL patients and healthy non-endemic controls (HNEC). Monocytes can broadly be divided into three subsets: classical, intermediate and non-classical monocytes. Our results show that the percentages of all three subsets stayed similar at the time of VL diagnosis (ToD) and at the end of anti-leishmanial treatment (EoT). We first looked at co-stimulatory receptors: the expression levels of CD40 were significantly increased on classical and intermediate, but not non-classical monocytes, at ToD as compared to EoT and HNEC. CD80 expression levels were also increased on intermediate monocytes at ToD as compared to EoT and HNEC, and on classical monocytes only as compared to HNEC. The levels of CD86 were similar at EoT and ToD and in HNEC on classical and intermediate monocytes, but significantly higher at EoT on non-classical monocytes. We also looked at an inhibitory molecule, PD-L1. Our results show that the expression levels of PD-L1 were significantly higher on all three monocyte subsets at ToD as compared to HNEC, and to EoT on classical and intermediate monocytes. These results show that monocytes from the blood of VL patients upregulate both co-stimulatory and inhibitory receptors and that their expression levels are restored at EoT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
- Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia.
- Department of Medical Laboratory Science, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
- Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia.
- Amhara Public Health Institute, Bahir Dar, Ethiopia.
- Department of Infectious Disease, Imperial College London, London, United Kingdom.
ORCID-Profile: Pascale Kropf
Förderung
- Wellcome Trust
Zitieren
APA
Adem, E., Yizengaw, E., Mulaw, T., Nibret, E., Müller, I., Takele, Y., & Kropf, P. (2024). Altered co-stimulatory and inhibitory receptors on monocyte subsets in patients with visceral leishmaniasis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012417
Vancouver
Adem E, Yizengaw E, Mulaw T, Nibret E, Müller I, Takele Y, et al. Altered co-stimulatory and inhibitory receptors on monocyte subsets in patients with visceral leishmaniasis. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012417
BibTeX
@article{Adem2024,
author = {Adem, Emebet and Yizengaw, Endalew and Mulaw, Tadele and Nibret, Endalkachew and Müller, Ingrid and Takele, Yegnasew and Kropf, Pascale},
title = {Altered co-stimulatory and inhibitory receptors on monocyte subsets in patients with visceral leishmaniasis},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012417}
}
EUVIMED